These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 6821030)

  • 61. The immune response to the capsular polysaccharide of Neisseria meningitidis group B.
    Romero JD; Outschoorn IM
    Zentralbl Bakteriol; 1997 Feb; 285(3):331-40. PubMed ID: 9084108
    [No Abstract]   [Full Text] [Related]  

  • 62. [Studies on serum meningococcal antibodies in patients with meningococcal meningitis and a healthy population].
    Pang HM
    Zhonghua Yu Fang Yi Xue Za Zhi; 1988 Jul; 22(4):233-5. PubMed ID: 3146488
    [No Abstract]   [Full Text] [Related]  

  • 63. [Bacterial polysaccharide vaccines: Meningococcus, Pneumococcus, Haemophilus influenzae].
    Triau R
    Rev Prat; 1984 Jun; 34(31):1683-90. PubMed ID: 6429835
    [No Abstract]   [Full Text] [Related]  

  • 64. Memory immune response generated in Cercopithecus aethiops against meningococcal polysaccharide serogroup C conjugate vaccine.
    Carmenate T; Guirola M; Alvarez A; Canaán L; González S; Caballero E; Menéndez T; Guillén G
    FEMS Immunol Med Microbiol; 2005 Feb; 43(2):133-40. PubMed ID: 15681142
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effectiveness of a trivalent serogroup A/C/W135 meningococcal polysaccharide vaccine in Burkina Faso, 2003.
    Soriano-Gabarró M; Toé L; Tiendrebeogo SR; Nelson CB; Dabal M; Djingarey MH; Plikaytis B; Rosenstein N;
    Vaccine; 2007 Sep; 25 Suppl 1():A92-6. PubMed ID: 17517451
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Control of meningococcal disease: the responsibility of all.
    Fogarty J
    Ir Med J; 1995; 88(1):14, 16. PubMed ID: 7737833
    [No Abstract]   [Full Text] [Related]  

  • 67. Immune responses to polysaccharides: lessons from humans and mice.
    González-Fernández A; Faro J; Fernández C
    Vaccine; 2008 Jan; 26(3):292-300. PubMed ID: 18160186
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Meningococcal disease in the Netherlands: media hype, but not an epidemic].
    van Furth AM; Zaaijer HL
    Ned Tijdschr Geneeskd; 2001 Sep; 145(36):1716-8. PubMed ID: 11572168
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Serological evaluation of polyvalent A-C anti-meningococcal vaccine in Chile].
    García Moreno J; Prat Miranda MS; Vicent P; Calderón B
    Bol Oficina Sanit Panam; 1982 Aug; 93(2):149-57. PubMed ID: 6215047
    [No Abstract]   [Full Text] [Related]  

  • 70. Neisseria meningitidis serogroup A vaccines: an overview.
    Vergnano S; Heath P
    Expert Rev Vaccines; 2003 Aug; 2(4):571-82. PubMed ID: 14711341
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Neisseria meningitidis: vaccines and vaccine candidates.
    Al'Aldeen AA; Cartwright KA
    J Infect; 1996 Nov; 33(3):153-7. PubMed ID: 8945702
    [No Abstract]   [Full Text] [Related]  

  • 72. Polysaccharide vaccines of group A Neisseria meningtitidis and Haemophilus influenzae type b: a field trial in Finland.
    Mäkelä PH; Peltola H; Käyhty H; Jousimies H; Pettay O; Ruoslahti E; Sivonen A; Renkonen OV
    J Infect Dis; 1977 Aug; 136 Suppl():S43-50. PubMed ID: 408432
    [No Abstract]   [Full Text] [Related]  

  • 73. [An animal model for testing the activity of meningococcal polysaccharide vaccine].
    Huet M; Suire A
    J Biol Stand; 1981 Jan; 9(1):67-74. PubMed ID: 6783665
    [No Abstract]   [Full Text] [Related]  

  • 74. Immunogenicity of O-acetyl-negative and -positive polysaccharide vaccines for infections with Neisseria meningitidis group C in infants.
    Pichichero M; Anderson P; Gotschlich E; Kamm J; McMullen A; Nielsen S
    J Infect Dis; 1985 Oct; 152(4):850-1. PubMed ID: 3930623
    [No Abstract]   [Full Text] [Related]  

  • 75. Susceptibility to meningococcal meningitis.
    Sabath LD; Rosner B
    N Engl J Med; 1973 May; 288(22):1185. PubMed ID: 4633552
    [No Abstract]   [Full Text] [Related]  

  • 76. Recurrent meningococcal meningitis due to partial complement defects and poor anti-meningococcal antibody response.
    Herva E; Leinonen M; Käyhty H; Mäkelä PH; Vetoniemi-Korhonen SL
    J Infect; 1983 Jan; 6(1):55-60. PubMed ID: 6411822
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Meningococcal C polysaccharide vaccine induces immunologic hyporesponsiveness in adults that is overcome by meningococcal C conjugate vaccine.
    Richmond P; Kaczmarski E; Borrow R; Findlow J; Clark S; McCann R; Hill J; Barker M; Miller E
    J Infect Dis; 2000 Feb; 181(2):761-4. PubMed ID: 10669372
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The role of complement in anti-bacterial defence.
    D'Amelio R; Biselli R
    Ann Ital Med Int; 1994; 9(3):173-7. PubMed ID: 7946895
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Immune Response of human infants of polysaccharide vaccines of group A and C Neisseria meningitidis.
    Gold R; Lepow ML; Goldschneider I; Gotschlich EC
    J Infect Dis; 1977 Aug; 136 Suppl():S31-5. PubMed ID: 408431
    [No Abstract]   [Full Text] [Related]  

  • 80. Antibody responses to meningococcal (groups A, C, Y and W135) polysaccharide diphtheria toxoid conjugate vaccine in children who previously received meningococcal C conjugate vaccine.
    El Bashir H; Heath PT; Papa T; Ruggeberg JU; Johnson N; Sinha R; Balfour G; Booy R
    Vaccine; 2006 Mar; 24(14):2544-9. PubMed ID: 16417952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.